HbA1c is a good indicator for blood glucose levels over a period of 8 – 12 weeks. This is particularly useful in diabetes where good, long-term glycaemic control is essential.  A reduction in HbA1c has been shown to reduce the risk of certain diabetes-related complications¹. Knowing your patient’s HbA1c levels at the time of consultation is vital in the management of the patient, and can be a powerful motivator for your patient to achieve better glycaemic control.

The A1CNow®+ professional system allows you to monitor the HbA1c levels in 5 minutes using a drop of fingerstick blood.  Fast, easy and accurate results - laboratory quality can be obtained in minutes.

References

1. UKPDS 35. BMJ 2000;321:405–12.

Important notes

In-vitro use only

In conjunction with a clinical assessment, the A1CNow®+ system can be used as a tool to help assist in the screening for diabetes, or diagnosis of diabetes as well as the more traditional use – that of monitoring diabetes.  All local guidelines for diagnosis or screening of diabetes should be followed.

To be used by trained healthcare professionals.

Highly Efficient

• Time saving
• Portable
• Re-usable
• Simple to use
• No fasting required.

The self-contained, integrated hand-held monitor requires no additional equipment and very minimal training.  Tests can be performed in any clinical setting.

Recognised

A1c Now+ is FDA approved, CLIA waived, certified by the National Glycohaemoglobin Standardisation Program (NGSP), International Federation of Clinical Chemistry (IFCC) traceable and CE marked.

The portable device is compact and easily stored.  It can be used in pharmacies, GP surgeries, research institutes, and occupational health, as well as in dentist surgeries, in ENT clinics and prior to lens implants in optometry.